Symposium: Advances in cancer drug discovery and development – 30 October
A collaborative symposium integrating industry, academia, and the clinic, discussing the latest advances in cancer drug discovery and immunotherapies is taking place on Tuesday 30 October 2018.
This unique, free full-day symposium, sponsored by Merck Sharp & Dohme (MSD), Cancer Therapeutics CRC (CTx), and the Victorian Comprehensive Cancer Centre, brings together leading industry, academic and clinical experts to discuss opportunities to progress biological discoveries to effective therapies, covering cancer drug discovery, development, and immunotherapies.
Who should attend?
This day of discussion and discovery will suit biomedical PhD students, researchers, clinical and allied health professionals, medical and pharmaceutical investors and life science analysts.
The program
Three program sessions cover “Harnessing the immune system to fight cancer”, “From biological discoveries to therapies”, and “Finding the right patients”. In addition to an exciting mix of local speakers, we will be joined by four keynote international speakers; John Connolly from the Agency for Science, Technology and Research Singapore, Dr Michael Rosenzweig, Executive Director, Biology-Discovery, MSD, Dr Jonathan Bennett, Associate Vic President Discovery Chemistry, MSD and Rachel Altura, MD, Clinical Director, Early Oncology Development MSD.
When:
Tuesday 30 October, 9.15 am – 4.15 pm
Format:
9.00 am – Arrival and registration
9.15 am – Symposium
4.15 pm – Networking event and refreshments
Location:
The Copland Theatre (B01), Basement
The University of Melbourne
198 Berkeley Street, Parkville
Please note Grattan St is closed nearby due to Metro Tunnel construction
RSVP:
Click here to RSVP at Eventbrite.
This is a free event but numbers are limited and registration is essential.
A VCCC event
This event is hosted by the Victorian Comprehensive Cancer Centre, and sponsored by Merck Sharp & Dohme and Cancer Therapeutics CRC.
